Yahoo
NasdaqGM - Nasdaq Real Time Price USD

Neuronetics, Inc. (STIM)

2.4750 -0.2300 (-8.50%)
As of 2:26:00 PM EST. Market Open.
STIM Q3 2026 earnings call
Replay the call for the latest insights.
Chart Range Bar
Loading chart for STIM
  • Previous Close 2.7050
  • Open 2.7000
  • Bid 1.7500 x 100
  • Ask 2.8600 x 200
  • Day's Range 2.4600 - 2.7150
  • 52 Week Range 0.8000 - 3.4400
  • Volume 1,171,851
  • Avg. Volume 1,672,437
  • Market Cap (intraday) 192.378M
  • Beta (5Y Monthly) 1.32
  • PE Ratio (TTM) --
  • EPS (TTM) -0.3200
  • Earnings Date Nov 4, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 5.75
  • Motley Fool Rating Bearish

Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. has a strategic collaboration with ANT Neuro to expand the capabilities of the NeuroStar advanced therapy system with advanced image-guided navigation technology. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

neurostar.com/neuronetics

658

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/5/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

STIM
79.35%
S&P 500 (^GSPC)
7.73%

1-Year Return

STIM
9.67%
S&P 500 (^GSPC)
8.51%

3-Year Return

STIM
76.79%
S&P 500 (^GSPC)
69.21%

5-Year Return

STIM
54.00%
S&P 500 (^GSPC)
56.99%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 41.96M
Earnings -1.69M
Profit Margin -4.03%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

-10M
0
10M
20M
30M
40M
-30.0%
-25.0%
-20.0%
-15.0%
-10.0%
-5.0%

Analyst Insights

View More

Analyst Price Targets

5.00
5.75 Average
2.4750 Current
7.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 9/17/2026
Analyst BTIG
Rating Action Reiterates
Rating Buy
Price Action Maintains
Price Target 6 -> 6

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -19.62%

  • Return on Assets (ttm)

    -10.55%

  • Return on Equity (ttm)

    -116.10%

  • Revenue (ttm)

    155.1M

  • Net Income Avi to Common (ttm)

    -30.43M

  • Diluted EPS (ttm)

    -0.3200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    19.2M

  • Total Debt/Equity (mrq)

    399.83%

  • Levered Free Cash Flow (ttm)

    345.62k

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: